by Steven Ertelt
August 27, 2006
Washington, DC (LifeNews.com) — Abortion advocates are admitting that FDA approval of over the counter sales of the morning after pill won’t reduce the number of unintended pregnancies or abortions. However, their admission comes long after pro-life advocates said the Plan B pills wouldn’t have the overwhelming effect pro-abortion groups claimed.
Before the FDA approval of selling the drugs to women over the age of 18, Planned Parenthood maintained the drug would prevent up to 1.5 million unplanned pregnancies and 800,000 abortions a year.
On Friday, the group backpedaled on those claims.
"It will not reach that potential," Jackie Payne, the abortion businesses’ director of government relations, told the Associated Press.
Payne, however, claimed that the FDA’s limits preventing the drug from being sold to girls under the age of 18 without a prescription would reduce the number of pregnancies and abortions it claims the pills would prevent.
James Trussell, director of the Office of Population Research at Princeton University, agreed with the revised estimate of what impact FDA approval will have and said it would be much lower than anticipated.
"That doesn’t mean zero, but it will be hard to measure because it will be so small," he told AP. "If you look at the number of acts of unprotected intercourse on one hand, and the use of Plan B on the other, it’s like a cork on the ocean."
A January 2005 study conducted by a Planned Parenthood medical director in San Francisco found that when women were give morning after pills to take home for future use, pregnancy rates were unaffected and women didn’t use the pills in as high a percentage as expected by increasing access.
"It really doesn’t work if it’s left in the drawer," Trussell said.
Others say the use of the morning after pill may be higher because men may force women to have sexual relations without any contraception — knowing they can tell a woman to buy the morning after pill the next day.
"Now they have one more reason to say: ‘I’m not going to use one. I’ll buy you the pill in the morning,’" 23 year-old student Elizabeth Jones from New York told the Times newspaper.
But Richard Salazar, 19, of Harlem, told the Times that he and his friends wouldn’t use the morning after pill because it doesn’t prevent against sexually transmitted diseases.
"It’s just preventing pregnancies; it’s not preventing AIDS,” he said. “Some people are going to be smart, some aren’t and that won’t change.”
Others say the use of the morning after pill will be lower than abortion advocates expected because Barr Pharmaceuticals, the maker of Plan B, will sell the drug at anywhere from $20 to $40 per pack, which could be too expensive for low income women and couples.